IVD Test Reagent/Kits, Serology, Bacteria, Treponema pallidum

Definition : Serology reagents intended to detect antibody titers or antigens of Treponema pallidum, a bacterium of the family Spirochaetaceae. These bacteria cause syphilis, a disease that is usually transmitted sexually or acquired in utero.

Entry Terms : "Reagents, Serology, Bacteria, Syphilis" , "IVD Test Reagent/Kits, Serology, Bacteria, Syphilis, Antigen" , "Treponema Species Detection/Identification Reagents" , "Treponema pallidum Reagents, Identification/Detection" , "Treponema pallidum Detection/Identification Reagents" , "Treponema pallidum Bacteria Identification/Detection Reagents" , "Syphilis Diagnostic Reagents" , "Reagents, Sexually Transmitted Disease" , "Reagents, Serology, Bacteria, Treponema pallidum"

UMDC code : 19002

Filters
Manufacturers
Distributors
U.S.companies only
Suppress Subsidiary Companies
   

1-4 of 4 Match(es).

DRG International Inc

Company Type: Parent

DRG International, Inc. is a leading specialty medical diagnostics and equipment manufacturer, and distributor with operations in more than 110 countries. Founded in 1970, DRG International provides a complete range of products and services to the diagnostics and cardiology-related medical community. DRG International's global headquarters is based in Mountainside, New Jersey

Hemagen Diagnostics Inc

Company Type: Parent

Hemagen Inc. was founded in 1985 by a group of scientists from the Boston University School of Medicine.

United Bio Research Inc

Company Type: Parent

United Biotech, Inc was founded in 1984. UBI develops and manufactures products tailored to the need of medical professionals in engineering healthcare economies. From conception, products are designed for reliability, ease of use and cost effectiveness. Our products are unique for clinical assays in that all assays can be used with any open-ended 96-well platform (eg. universal microtiter plate reader).

Zeus Scientific Inc

Company Type: Parent

ZEUS Scientific is a privately held corporation that was founded in 1976. The company began producing IFA (immunofluorescence assay) test systems followed ELISA and now multiplex (AtheNA Multi-Lyte) immunoassays. New products are developed to expand the menu which allows laboratories to run an increasing number of assays with common protocols and common reagents, as well as developing new tests to more accurately diagnose patients. In 1987 ZEUS Scientific was the first company to develop, receive appropriate regulatory clearance and bring to market a serological assay to test for Lyme disease – a condition with high prevalence in the local community where ZEUS Scientific is located.

1-4 of 4 Match(es).

 

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs
Medical Product Guide Cancer Therapy Advisor Product Zone